Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ESMO Open|August 11, 2018
Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapyChristopher Nevala-Plagemann, Samual Francis, Courtney Cavalieri, et al.Annals of Surgical Oncology|October 19, 2017
Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched AnalysisAnna Torgeson, Shane Lloyd, Dustin Boothe, et al.Haematologica|October 1, 2013
Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defectsSabina Swierczek, Archana M Agarwal, Kubendran Naidoo, et al.BMC Research Notes|February 16, 2023
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)Matthew Gumbleton, Stephanie Allan, Hannah Conway, et al.Investigational New Drugs|October 11, 2018
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancerG Weldon Gilcrease, David D Stenehjem, Mark L Wade, et al.The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 13, 2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018Manisha H Shah, Whitney S Goldner, Thorvardur R Halfdanarson, et al.Pageof 2